4P-Pharma is excited to take the stage at the 3rd Annual Paris Digital Science & Innovation Day, hosted by Benchling, on 18 November at Les Salons Hoche, Paris! 🇫🇷
Our CEO, Revital Rattenbach, will share how AI is ushering in a new era of virtual drug development, transforming how we generate evidence and design clinical studies, including:
✔️ How AI-driven patient stratification and virtual control arms are improving trial efficiency and reducing patient burden
✔️ How hybrid virtual trials inform study design before human execution, increasing the chances of success from the start
✔️ The future of virtual efficacy evaluation, where targeted real-world validation accelerates access and reduces costs
Join 200+ R&D leaders, scientists, and innovators to explore how AI, data, and digital transformation are redefining the future of biopharma.
